Doxepin HCL Tablet
Doxepin HCL is a compounded formulation containing Doxepin HCL, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider doxepin for patients presented with dermatological or behavioral challenges. In the context of skin conditions, it is frequently discussed for managing psychogenic dermatoses or chronic itching (pruritus) where a psychological component is suspected. It is also one option veterinarians may consider for the management of situational anxiety, noise aversions or certain types of compulsive behaviors.
At a pharmacological level, doxepin acts as a non-selective reuptake inhibitor of serotonin and norepinephrine within the central nervous system. This mechanism manages the concentration of these neurotransmitters at the synaptic cleft, providing a method for modulating mood and behavioral responses. Additionally, doxepin is characterized by its potent antagonistic activity at H1 and H2 histamine receptors, which is significantly more pronounced than that of many traditional antihistamines. This mechanism manages the physiological response to histamine, provide a method for managing localized allergic irritation. Your veterinarian will determine whether doxepin is appropriate for your pet based on their clinical signs, weight and overall health status.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects following the administration of doxepin include sedation, lethargy and localized digestive changes such as dry mouth (xerostomia), vomiting or constipation. Because it possesses anticholinergic properties, your veterinarian will monitor for observational signs such as increased heart rate (tachycardia) or urinary retention. Owners should monitor their pet for any significant behavioral shifts or changes in appetite and contact their veterinarian promptly with any concerns regarding the patient’s response to the medication.
This medication is typically used with extra caution or avoided in patients with known cardiovascular disease, glaucoma, a history of seizures or urinary retention. It is also carefully evaluated in pets presented with severe hepatic or renal impairment. Significant interactions can occur if doxepin is administered concurrently with monoamine oxidase inhibitors (MAOIs), other central nervous system depressants or certain behavioral medications that influence serotonin levels. Sudden discontinuation of doxepin is generally avoided to manage the risk of withdrawal-like signs; your veterinarian is the right person to provide guidance on a proper tapering schedule and the necessary monitoring required to ensure the management approach remains suitable for your pet's needs.
Yes. Doxepin is a prescription medication and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all legal requirements before preparing or shipping any medication to your home.
Yes. While doxepin is available in certain commercial capsule formats for humans, Mixlab specializes in compounding the active ingredient into customized strengths and flavored dosage forms—such as flavored oral liquids or treats—to suit the specific needs and weight of your pet. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss doxepin for skin conditions because it blocks histamine receptors while simultaneously managing the behavioral urge to lick or scratch. This dual mechanism provides a method for managing cases where itching and anxiety are both clinical concerns.
Sedation and lethargy are commonly observed effects of tricyclic antidepressants like doxepin. Your veterinarian will provide guidance on what level of drowsiness is expected and when you should contact them if your pet appears unusually tired during the management course.
The timeline for observational signs of improvement varies depending on the condition being addressed, as behavioral shifts may take several weeks to become apparent. Your veterinarian will provide guidance on the expected timeline and the proper monitoring schedule for your pet's specific management plan.
